New Pneumococcal Vaccine Study

–Recruitment closed–

Participants needed: Babies who are 2 months of age

Why are we doing this study: Pneumococcal disease is caused by the bacteria Streptococcus pneumoniae (SP) and can lead to serious complications such as brain damage, hearing loss, and death. Children under 2 years of age are at highest risk. The current vaccine is more than 90% effective in protecting infants and young children against 13 types of SP. Researchers would like to evaluate a newer vaccine to protect children against 15 types of SP.

The study involves: 5 -6 vists over 11 months. Visits will include pneumococcal vaccination, all routine vaccinations for your baby’s first year, and questions about your baby’s health.

You will receive: Eligible participants will be reimbursed for travel/ parking and for their time.

To learn more please contact us.